Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$142K Buy
+20,448
New +$121K 0.02% 847
2026
Q1
Sell
-32,664
Closed -$217K 981
2025
Q4
$217K Buy
32,664
+5,459
+20% +$37K 0.03% 784
2025
Q3
$167K Buy
+27,205
New +$212K 0.03% 831
2024
Q1
Sell
-18,996
Closed -$200K 846
2023
Q4
$200K Buy
+18,996
New +$170K 0.05% 635
2023
Q1
Sell
-10,864
Closed -$81.6K 730
2022
Q4
$81.6K Buy
+10,864
New +$84.1K 0.03% 573
2021
Q4
Sell
-10,340
Closed -$79K 537
2021
Q3
$79K Buy
+10,340
New +$107K 0.05% 440

Other funds holding EOLS

Fox Run Management's EOLS Position: Q2 2026 in Review

Fox Run Management opened a new position in Evolus (EOLS) in Q2 2026: 20,448 shares worth $142K. The stake represents 0.02% of the portfolio and ranks #847 among its holdings. This is a return to the name: Fox Run Management previously reported a position in EOLS as recently as Q4 2025.

Fox Run Management first reported a position in EOLS in Q3 2021 and has held it in 6 quarters since. The position peaked at $217K in Q4 2025. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Fox Run Management held 20,448 shares of Evolus worth $142K as of Q2 2026.
  • Evolus was a new Fox Run Management position in Q2 2026.
  • Evolus made up 0.02% of Fox Run Management's portfolio in Q2 2026, its #847 holding.
  • Fox Run Management first reported a position in Evolus in Q3 2021 and has held it in 6 quarters since.
  • Fox Run Management's Evolus position peaked at $217K in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.